Página 2 - Melhores Condrossarcoma médicos - TOP-62 médicos

O Dr. Ahmet Bilici é um renomado oncologista médico especializado no tratamento de sarcomas e cancro do pulmão no Hospital Universitário Medipol Mega.

• Mais de 20 anos de experiência dedicada em oncologia
• Experiência no tratamento de casos de sarcomas raros e complexos
• Reconhecido como um dos principais especialistas em sarcomas da Turquia

A Prof. Elke Jaeger é uma das maiores especialistas em sarcoma da Alemanha, de acordo com a classificação da Focus, com mais de 35 anos de prática.

• Chefe de Oncologia e Hematologia na Clínica Nordwest
• Reconhecida como uma das melhores oncologistas da Alemanha
• Especializar-se no tratamento de sarcoma

Diretor de hematologia e oncologia pediátrica no Sourasky Medical Center – especializado no tratamento de câncer ósseo em crianças.

• Especialista no tratamento de sarcoma em crianças
• Formado no Instituto Ortopédico Rizzoli – um centro líder mundial
• Coordenar o tratamento do câncer ósseo com equipes de oncologia ortopédica
• Membro da ISPHO – Associação Israelense de Hemato-Oncologia Pediátrica

O Dr. Yildiz é especialista em tumores neuroendócrinos e é autor de mais de 17 artigos internacionais com revisão por pares, incluindo sobre condições relacionadas ao condrossarcoma.

• Publicar pesquisas sobre casos de tumores raros, como pênfigo paraneoplásico e timoma
• Experiência no diagnóstico e tratamento de cancros endócrinos complexos
• Trabalhar no Hospital Universitário Medipol Mega – um centro médico turco de referência

O Dr. Alemdar é especialista em condrossarcoma no Medical Park Antalya, trazendo expertise oncológica focada em casos raros de cancro ósseo.

• Certificado em oncologia médica com formação extensiva
• Experiência em vários hospitais universitários turcos de prestígio
• Especialização em medicina interna antes da especialização em oncologia

Chefia um departamento dedicado a lesões ósseas metastáticas no Ichilov Medical Center – um dos maiores hospitais de Israel.

• Especializar-se exclusivamente em ortopedia oncológica, tratando cancros ósseos.
• Realizar estágios clínicos avançados em Israel e nos Estados Unidos.
• Deter um cargo académico sénior como Professor na Universidade de Tel Aviv.
• Formar-se na prestigiada Universidade Hebraica de Jerusalém.

O Dr. Amir é especialista em cirurgia de preservação de membros para cancros ósseos e de tecidos moles no Centro Médico Sourasky de Israel (Ichilov).

• Formação especializada (Fellowship) em oncologia ortopédica no National Cancer Institute dos EUA e na Universidade de Toronto
• Membro ativo da American Musculoskeletal Tumor Society (MSTS) e da International Society of Limb Salvage (ISOLS)
• Vencedor de vários prémios, incluindo a Bolsa Tannenbaum por excelência em oncologia cirúrgica
• Especializado em sarcomas, com perícia em casos complexos que requerem técnicas reconstrutivas

O Prof. Köstler é especialista em terapias oncológicas direcionadas, com mais de duas décadas de experiência em tratamento oncológico individualizado na Wiener Privatklinik.

• Especialista em cancro da mama e neoplasias ginecológicas
• Professor Associado na Universidade Médica de Viena
• Foco no desenvolvimento de biomarcadores e biologia tumoral
• Participante ativo em redes europeias de oncologia

O Professor Keil lidera a Clínica de Radiologia Diagnóstica e Intervencionista do Hospital Académico de Solingen, especializando-se em exames de imagem avançados para casos complexos.

• Graduado com honras pela Julius-Maximilians-Universität Würzburg
• Especialista em ressonância magnética, tomografia computadorizada e intervenções guiadas por ultrassom
• Antigo médico-chefe no Hospital Universitário de Aachen
• Especializado em imagiologia de secção transversal para todas as regiões do corpo

O Prof. Assoc. Nail Paksoy traz conhecimentos especializados em sarcomas ósseos do Instituto de Oncologia da Universidade de Istambul, liderando agora o tratamento de condrossarcoma no Hospital Medipol Bahçelievler.

• Ser certificado em oncologia médica pela ESMO
• Escrever pesquisas fundamentais sobre quimioterapia de alta dose para o sarcoma de Ewing e outros tumores ósseos
• Participar em ensaios internacionais para tumores sólidos com fusão NTRK
• Realizar formação especializada num dos principais centros de oncologia da Turquia

Dr. Irfan Cicin is a Professor of Medical Oncology at the Trakya University Faculty of Medicine (2015–present). He has over 20 years of medical oncology experience and has held academic roles since 2010.

Education: MD, Istanbul University – Cerrahpaşa (1991–1997). Residency in Internal Medicine, Trakya University (1997–2002). Fellowship in Medical Oncology, Trakya University (2002–2004).

Practice: Medical Oncologist, Trakya University (2005–2008). Medical Oncologist, Elazığ Training and Research Hospital (2008–2010). Associate Professor of Medical Oncology, Trakya University (2010–2015). He previously served as a physician in the Turkish Air Force at Etimesgut Military Hospital (2004–2005).

Dr. Mariam Mohammed Hussein Abu Zeid is a clinical oncologist. She treats solid tumors and hematologic cancers. She earned her MBBCh from Ain Shams University in 2007 (Excellent). She completed a Master’s in Clinical Oncology and Nuclear Medicine in 2011 (Very Good). She received a Ph.D. in 2018 and an ESMO Certificate in 2015.

She leads and monitors clinical trials. Her work includes data collection and analysis. She administers chemotherapy and manages treatment toxicities. She also plans care with multidisciplinary teams. Her experience includes Ain Shams University Hospitals (2009–2012), the International Medical Center (2012–2014), and Wadi El Nile Hospital (2015–2019). Her roles covered diagnosis and staging, supportive care, quality improvement, and screening. She educates patients and families about the diagnosis, treatment options, and palliative care.

Assoc. Prof. Atakan Topçu, M.D., is a medical oncologist at Medipol University and Medipol Acıbadem Regional Hospital. He treats solid tumors, including lung, breast, colorectal, gastric, and neuroendocrine cancers. His work also covers targeted therapies, immunotherapy, geriatric oncology, and cancer-related malnutrition, cachexia, and sarcopenia.

He has authored more than 50 peer-reviewed papers. Recent work includes a 2024 Frontiers in Medicine study on geriatric syndromes and a 2023 Future Oncology paper on sarcopenia and anxiety in lung cancer. He has also published on the CONUT score in breast cancer and on malnutrition in HER2-negative metastatic gastric cancer.

Dr. Topçu serves on the Editorial Board of BMC Cancer. He is a member of the Turkish Society of Medical Oncology, ESMO, and the Turkish Geriatrics Society. Education and training: M.D., Uludağ University; residency in Internal Medicine, Marmara University; fellowship in Medical Oncology, Bezmialem Vakıf University.

Professor Shixin Liu, MD, PhD, is the Discipline Leader of the Oncology Center. He is the former President of Jilin Provincial Cancer Hospital and former Director of the Cancer Prevention and Treatment Research Institute. He is a second-level professor and doctoral supervisor. He has received the State Council Special Government Allowance, the 4th National Famous Doctor (Outstanding Contribution) award, and the Model of Medical Ethics honor.

He specializes in the comprehensive diagnosis and treatment of malignant tumors. His focus is precision radiotherapy for thoracic and abdominal cancers. He is skilled in IMRT, VMAT, and SBRT for lung, esophageal, breast, and rectal cancers.

His leadership roles include Vice Chair of CMA Radiation Oncology, CACA Radiotherapy, and CACA Particle Therapy. He serves on the CSCO Standing Committee and as Vice Chair of the CSCO Radiation Oncology Expert Committee. He is Vice Chair of CPAM Radiation Oncology and a Standing Committee member of CSMEA. He chairs the Jilin Medical Association Radiation Oncology branch. He is on the editorial boards of the Chinese Journal of Radiation Oncology and the Practical Journal of Cancer.

Especializada em viroterapia – um dos mais recentes campos da imunologia – a Dra. Jaunalksne traz mais de 30 anos de experiência no tratamento do condrossarcoma.

• Chefe do Centro de Imunologia Clínica do Hospital Universitário Clínico Pauls Stradins
• Graduada pelo Instituto Médico de Riga com internato em Medicina Interna
• Focar em abordagens imunológicas inovadoras para o tratamento do cancro

Dr. Mohamed Mahmoud Abdelhakim is Head of Radiation Oncology at Shefa al Orman Hospital, Luxor. He is Professor of Radiation Oncology at the National Cancer Institute, Cairo University. He previously served as Associate Professor (2015–2020), Lecturer (2010–2015), Assistant Lecturer (2003–2009), and Resident (2000–2003). He also worked as a Specialist at Gharbia Cancer Society.

He treats inpatients and outpatients with breast, soft tissue sarcoma, lymphoma, gynecologic, gastrointestinal, genitourinary, and CNS tumors. His skills include image-guided brachytherapy, IMRT, VMAT, SRS, and SBRT. He performs conventional and CT-based planning and 3D-CRT. He works with cobalt and linear accelerators and electron beam therapy. He provides HDR and LDR intracavitary and interstitial brachytherapy. He also performs stereotactic radiotherapy, total body irradiation, and total skin irradiation.

Member: Egyptian Cancer Society, ESTRO, ESMO.

Dr. Maha Yahia is a medical oncologist and hemato-oncologist. She provides assessment, diagnosis, and treatment planning. Her treatments include chemotherapy, targeted therapy, and immunotherapy. She cares for patients with breast, genitourinary, gynecologic, thoracic, gastrointestinal, and rare cancers.

Education: M.B.B.Ch, Kasr El-Aini, Cairo University (1997–2003). Master in Hemato-oncology, National Cancer Institute, Cairo University (2008). Doctoral Degree in Hemato-oncology, National Cancer Institute, Cairo University (2015).

Experience: Resident in Medical Oncology, Maadi AFMC (2005–2010). Visitor Resident, NCI Cairo (2008–2009). Consultant Assistant, Prof. Hussein Khaled Clinic (2010–2017). Specialist, International Medical Center (2011–2012), Wadi El Nile Hospital (2013–2014), and Maadi AFMC (2011–2018). Head, Clinical Research Support Team, Maadi AFMC (2016–2018). Major (2014–2016) and Lt. Colonel Doctor (2016–2018), Egyptian Armed Forces. Lecturer of Clinical Research, AFCM (2019–2021).

Dr. Emad Shash, M.B.B.Ch, MSc, M.D., is a medical oncologist. He is the Medical Director of the Breast Comprehensive Cancer Hospital at NCI. He leads the Medical Oncology Department and is the Breast Program Director at Shifaa Al Orman Cancer Hospital in Luxor. His clinical focus includes breast, gynecologic, genitourinary, thoracic, gastrointestinal, and rare cancers. He specializes in systemic therapy, including chemotherapy, targeted therapy, and immunotherapy.

He served as coordinating research physician and medical lead at the EORTC from 2011 to 2015. Since 2008, he has contributed to more than 70 international oncology trials as a coordinator, sub-investigator, principal investigator, and sponsor medical monitor. Credentials include M.B.B.Ch (2004), MSc (2010), MD (2015), and the EORTC Certificate of Excellence (2015). He also holds a Diploma in Hospital Quality Management & Patient Safety (JCI/57357, 2017). He is a Fellow of the EIO. He is a member of ESMO (panel voting), ESGO, and ASCO (IAC), and serves on the ECRIN board.

Assoc. Prof. Ayşe İrem Yasin, M.D., is a medical oncologist who specializes in solid tumors. Her clinical focus includes breast, lung, gastrointestinal, gynecologic, and urologic cancers. She also treats brain and other CNS tumors, soft tissue sarcomas, head and neck cancers, adenocarcinomas, melanoma, Merkel cell carcinoma, and cancers of unknown primary. She practices at Medipol Acıbadem District Hospital (2025–present). She previously worked at Şişli Etfal Training and Research Hospital (2023–2025).

She completed a Medical Oncology fellowship at Bezmialem Vakıf University (2019–2022). This followed an Internal Medicine residency at the same institution (2012–2016). Her international experience includes the Breast Cancer Unit at the University of Piemonte Orientale in Novara (2022). She also trained at Basel University Hospital, Cleveland Clinic, and Harvard Medical School. She holds the ESMO Board Certificate (2022).